BIGG

Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline

Farrell, B; Black, C; Thompson, W; McCarthy, L; Rojas-Fernandez, C; Lochnan, H; Shamji, S; Upshur, R; Bouchard, M; Welch, V.

Can. fam. physician; 63 (11), 2017

OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper, stop, or switch antihyperglycemic agents in older adults. METHODS: We focused on the highest level of evidence available and sought input from primary care professionals in guideline de...

Hiperglucemia/tratamiento farmacológico, Hipoglucemiantes/administración & dosificación, Receptores de Sulfonilureas/efectos de los fármacos, Diabetes Mellitus/tratamiento farmacológico, Toma de Decisiones Clínicas, Hipoglucemiantes/efectos adversos, Deprescripciones, Insulina/administración & dosificación, Insulina/efectos adversos

Texto completo

Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus

DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...